Baxter InternationalRegister for a premium account to gain access to Sterling AI.
Get StartedThings you can ask Sterling:
Baxter International (BAX) reported revenue of $2.96B in Q2 2026, with Medical Products & Therapies its largest revenue segment at 72%.
Baxter InternationalBaxter sells hospital infusion therapies, advanced surgery products, and connected care equipment. It sold its Kidney Care business (now Vantive) to Carlyle on January 31, 2025 and reports those results as discontinued operations.
Baxter International (BAX) is a Health Care Equipment company. Baxter sells hospital infusion therapies, advanced surgery products, and connected care equipment. It sold its Kidney Care business (now Vantive) to Carlyle on January 31, 2025 and reports those results as discontinued operations. It was founded in 1931, is headquartered in Deerfield, Illinois and employs about 37,500 people.
As of 2026-Q2, Baxter International's revenue breaks down across Medical Products & Therapies (72%), Healthcare Systems and Technologies (28%). See the revenue-by-segment chart for the full mix.
Track Baxter International's quarterly and annual revenue, gross and net margins, and EPS in the interactive charts on this page. Data last updated August 26, 2026.
Sterling groups Baxter International in the Healthcare sector, alongside Abbott Laboratories (ABT), Becton Dickinson (BDX), Boston Scientific (BSX), Edwards Lifesciences (EW), GE HealthCare (GEHC) and Idexx Laboratories (IDXX).
If you are researching Baxter International, also look at Abbott Laboratories (ABT), Becton Dickinson (BDX) and Boston Scientific (BSX). You can compare all of them side by side or browse the full Healthcare sector on Sterling.
Q3 2016-Q2 2026
Q3 2016-Q2 2026